An Audit of Antiretroviral Prescribing in HIV Patients

BHIVA Guidelines Co-ordinating Committee. British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. Lancet 1997; 349: 1086–92

Craig J.M. , Rogstad K.E. , Kinghorn G.R. . DELTA in the provinces — six months on (Abstract SV2-2). MSSVD Spring Meeting, Edinburgh, UK. May 1996

Ribeiro M. , Choudry A. , Skinner C. . Uptake of antiretroviral therapy and prescribing patterns at a London HIV centre (Abstract P27). 5th Annual Meeting BHIVA, Cambridge, UK. March 1999

Carpenter C.J. , Fischl M.A. , Hammer S.M. . Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society — USA Panel. JAMA 1997; 227: 1962–9

Hammer S.M. , Squires K.E. , Hughes M.D. . A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 counts of 200 per cubic millimeter or less. N Engl J Med 1997; 337: 725–33

Kitahaya M.M. , Koepsell T.D. , Deyo R.A. . Physicians’ experience with acquired immune deficiency syndrome as a factor in patients’ survival. N Engl J Med 1996; 334: 701–6

Gazzard B. , Moyle G. . 1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. Lancet 1998; 352: 314–16